612 related articles for article (PubMed ID: 17149698)
21. Global microRNA profiling of pancreatic neuroendocrine neoplasias.
Thorns C; Schurmann C; Gebauer N; Wallaschofski H; Kümpers C; Bernard V; Feller AC; Keck T; Habermann JK; Begum N; Lehnert H; Brabant G
Anticancer Res; 2014 May; 34(5):2249-54. PubMed ID: 24778027
[TBL] [Abstract][Full Text] [Related]
22. Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas.
Yabushita S; Fukamachi K; Tanaka H; Sumida K; Deguchi Y; Sukata T; Kawamura S; Uwagawa S; Suzui M; Tsuda H
Pancreas; 2012 Oct; 41(7):1013-8. PubMed ID: 22513294
[TBL] [Abstract][Full Text] [Related]
23. Postoperative prognosis prediction of pancreatic cancer with seven microRNAs.
Lee KH; Lee JK; Choi DW; Do IG; Sohn I; Jang KT; Jung SH; Heo JS; Choi SH; Lee KT
Pancreas; 2015 Jul; 44(5):764-8. PubMed ID: 25906450
[TBL] [Abstract][Full Text] [Related]
24. Micro RNA-373 is down-regulated in pancreatic cancer and inhibits cancer cell invasion.
Nakata K; Ohuchida K; Mizumoto K; Aishima S; Oda Y; Nagai E; Tanaka M
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S564-74. PubMed ID: 24748127
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic microRNAs in stage II colon cancer.
Schepeler T; Reinert JT; Ostenfeld MS; Christensen LL; Silahtaroglu AN; Dyrskjøt L; Wiuf C; Sørensen FJ; Kruhøffer M; Laurberg S; Kauppinen S; Ørntoft TF; Andersen CL
Cancer Res; 2008 Aug; 68(15):6416-24. PubMed ID: 18676867
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA profiling in periampullary carcinoma.
Kalluri Sai Shiva UM; Kuruva MM; Mitnala S; Rupjyoti T; Guduru Venkat R; Botlagunta S; Kandagaddala R; Siddapuram SP; Sekaran A; Chemalakonda R; Rebala P; Duvvuru NR
Pancreatology; 2014; 14(1):36-47. PubMed ID: 24555977
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma.
Panarelli NC; Chen YT; Zhou XK; Kitabayashi N; Yantiss RK
Pancreas; 2012 Jul; 41(5):685-90. PubMed ID: 22466166
[TBL] [Abstract][Full Text] [Related]
29. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival.
Greither T; Grochola LF; Udelnow A; Lautenschläger C; Würl P; Taubert H
Int J Cancer; 2010 Jan; 126(1):73-80. PubMed ID: 19551852
[TBL] [Abstract][Full Text] [Related]
30. EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas.
Mees ST; Mardin WA; Wendel C; Baeumer N; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Int J Cancer; 2010 Jan; 126(1):114-24. PubMed ID: 19569050
[TBL] [Abstract][Full Text] [Related]
31. Salivary MicroRNA in Pancreatic Cancer Patients.
Humeau M; Vignolle-Vidoni A; Sicard F; Martins F; Bournet B; Buscail L; Torrisani J; Cordelier P
PLoS One; 2015; 10(6):e0130996. PubMed ID: 26121640
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.
Zhao C; Zhang J; Zhang S; Yu D; Chen Y; Liu Q; Shi M; Ni C; Zhu M
Oncol Rep; 2013 Jul; 30(1):276-84. PubMed ID: 23612862
[TBL] [Abstract][Full Text] [Related]
33. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
[TBL] [Abstract][Full Text] [Related]
34. Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells.
Laurila EM; Sandström S; Rantanen LM; Autio R; Kallioniemi A
Genes Chromosomes Cancer; 2012 Jun; 51(6):557-68. PubMed ID: 22344632
[TBL] [Abstract][Full Text] [Related]
35. A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data.
Shi XH; Li X; Zhang H; He RZ; Zhao Y; Zhou M; Pan ST; Zhao CL; Feng YC; Wang M; Guo XJ; Qin RY
Sci Rep; 2018 May; 8(1):7638. PubMed ID: 29769534
[TBL] [Abstract][Full Text] [Related]
36. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.
Collins AL; Wojcik S; Liu J; Frankel WL; Alder H; Yu L; Schmittgen TD; Croce CM; Bloomston M
Ann Surg Oncol; 2014 Jan; 21(1):133-8. PubMed ID: 24046106
[TBL] [Abstract][Full Text] [Related]
37. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
[TBL] [Abstract][Full Text] [Related]
38. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2.
Ma Y; Yu S; Zhao W; Lu Z; Chen J
Cancer Lett; 2010 Dec; 298(2):150-8. PubMed ID: 20638779
[TBL] [Abstract][Full Text] [Related]
39. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
Wang WS; Liu LX; Li GP; Chen Y; Li CY; Jin DY; Wang XL
Cancer Prev Res (Phila); 2013 Apr; 6(4):331-8. PubMed ID: 23430754
[TBL] [Abstract][Full Text] [Related]
40. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model.
Rachagani S; Macha MA; Menning MS; Dey P; Pai P; Smith LM; Mo YY; Batra SK
Oncotarget; 2015 Nov; 6(37):40295-309. PubMed ID: 26516699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
